Search Within

Maria Irene Rodriguez-Sanchez

  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (2)
Groups
  1. Bone Marrow Transplant (7)
  2. CTCR Scholars (7)
  3. Center for Hematologic Malignancies (7)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (7)
  5. Department of Medicine (7)
  6. GSK Faculty (7)

More Groups

People
  1. Parastoo Dahi (7)
  2. Richard O'Reilly (7)
  3. Susan Prockop (7)
  4. Ekaterina Doubrovina (6)
  5. Aisha Hasan (4)
  6. Audrey Mauguen (4)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2020 (2)
  4. 2017 (2)
  5. 2016 (1)
Publications
  1. Blood (2)
  2. Bone Marrow Transplantation (2)
  3. Biology of Blood and Marrow Transplantation (1)
  4. Blood Advances (1)
  5. Journal of Clinical Investigation (1)
Publishers
  1. American Society of Hematology (3)
  2. Nature Publishing Group (2)
  3. American Society for Clinical Investigation (1)
  4. Elsevier Inc. (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
    Journal Article

    Prockop, S. E.; Hasan, A.; Doubrovina, E.; Dahi, P. B.; Rodriguez-Sanchez, I.; Curry, M.; Mauguen, A.; Papanicolaou, G. A.; Su, Y.; Yao, J.; more...
    Journal of Clinical Investigation (2023)

    Fulltext@MSK | Save
  • Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4(+) immunity to mediate durable responses
    Journal Article

    Fabrizio, V. A.; Rodriguez-Sanchez, M. I.; Mauguen, A.; Dahi, P. B.; Doubrovina, E.; O'Reilly, R. J.; Prockop, S. E.
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Baseline immune status predicts response to adoptive therapy with CMV CTLS for refractory CMV
    Meeting Abstract

    Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P.; Doubrovina, E.; O'Reilly, R. J.; Prockop, S.
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Baseline immune status predicts response to adoptive therapy with CMV cytotoxic T-Cells for refractory CMV
    Meeting Abstract

    Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P. B.; O'Reilly, R. J.; Prockop, S. E.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Adoptive T-cell therapy with 3rd party CMV-pp65-specific CTLs for CMV viremia and disease arising after allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Rodriguez-Sanchez, I.; Hasan, A. N.; Barker, J.; Castro-Malaspina, H. R.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Kernan, N. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Five years of therapy with donor and 3rd party derived EBV and CMV specific cytotoxic T cells - Safety after more than 1,000 infusions
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A.; Koehne, G.; Dahi, P.; Papadopoulos, E.; Sauter, C.; Rodriguez-Sanchez, I.; Suser, S.; Escobedo, V.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Third party CMV-specific cytotoxic T cells for treatment of antiviral resistant CMV infection after hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A. N.; Dahi, P. B.; Giralt, S.; Koehne, G.; Kernan, N. A.; Papadopoulos, E. B.; Lehrman, R.; Rodriguez-Sanchez, I.; more...
    Blood (2016)

    Fulltext@MSK | Save